Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Pre-funded warrant	Common Stock	Common Stock Pre-funded warrant	Additional Paid-In Capital	Additional Paid-In Capital Pre-funded warrant	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022	$ 372,207		$ 5		$ 690,814		$ (317,933)	$ (679)
Beginning Balance, Shares at Dec. 31, 2022			48,877,806
Vesting of shares of common stock subject to repurchase	2				2
Vesting of shares of common stock subject to repurchase, Shares			508
Issuance of common stock upon exercise of stock options	161				161
Issuance of common stock upon exercise of stock options, Shares			49,871
Issuance of common stock upon vesting of restricted stock units, Shares			88,543
Issuance of common stock under employee stock purchase plan	530				530
Issuance of common stock under employee stock purchase plan, Shares			164,567
Share-based compensation expense	17,199				17,199
Net unrealized gain on investments	687							687
Net loss	(117,501)						(117,501)
Ending Balance at Dec. 31, 2023	273,285		$ 5		708,706		(435,434)	8
Ending Balance, Shares at Dec. 31, 2023			49,181,295
Issuance of common stock, net of issuance costs		$ 225,073		$ 2		$ 225,071
Issuance of common stock, net of issuance costs, Shares				21,010,000
Issuance of common stock upon exercise of stock options	668				668
Issuance of common stock upon exercise of stock options, Shares			144,128
Issuance of common stock upon vesting of restricted stock units, Shares			165,667
Issuance of common stock under employee stock purchase plan	343				343
Issuance of common stock under employee stock purchase plan, Shares			144,049
Share-based compensation expense	16,731				16,731
Net unrealized gain on investments	666							666
Net loss	(108,790)						(108,790)
Ending Balance at Dec. 31, 2024	$ 407,976		$ 7		$ 951,519		$ (544,224)	$ 674
Ending Balance, Shares at Dec. 31, 2024			70,645,139